Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration [PDF]
Background Fluralaner is a novel systemic insecticide and acaricide. The purpose of these studies was to investigate the pharmacokinetic properties of fluralaner in Beagle dogs following single oral or intravenous (i.v.) administration. Methods Following
Susanne Kilp +4 more
doaj +3 more sources
Treatment of dogs with Bravecto® (fluralaner) reduces mosquito survival and fecundity
Background Mosquitoes serve as the vector of canine heartworm (Dirofilaria immitis), which represents a significant and persistent threat to canine health. A reduction in the longevity and/or reproductive success of mosquitoes that take a blood meal from
Christopher Charles Evans +5 more
doaj +3 more sources
Fluralaner activity against life stages of ticks using Rhipicephalus sanguineus and Ornithodoros moubata IN in vitro contact and feeding assays [PDF]
Background Fluralaner is a novel isoxazoline eliciting both acaricidal and insecticidal activity through potent blockage of GABA- and glutamate-gated chloride channels.
Heike Williams +4 more
doaj +2 more sources
Background Haemaphysalis longicornis ticks represent an ectoparasitic health threat to dogs. This study evaluated the immediate and persistent efficacy of orally administered fluralaner for control of this tick.
Masanori Toyota +4 more
doaj +2 more sources
Fluralaner treatment of chickens kills the southern house mosquito, Culex quinquefasciatus. [PDF]
Abstract The control of zoonotic and vector‐borne pathogens is challenging due to the limited availability of intervention tools. West Nile virus (WNV) is an example of a globally distributed zoonotic arbovirus that circulates between Culex species (Diptera: Culicidae ...
Knape K +7 more
europepmc +4 more sources
Fecal elimination of fluralaner in different carnivore species after oral administration [PDF]
Fluralaner is a recent external parasiticide, first of a new class of drugs (isoxazoline parasiticides). It is widely used in companion animals both for its wide spectrum (fleas, ticks and other mites) but also for its ease of use (oral tablets given once for 1 to three months).
Berny PJ, Belhadj D, España B, Lécu A.
exaly +5 more sources
SPECTROFLUORIMETRIC DETERMINATION AND OPTIMIZATION OF FLURALANER IN PHARMACEUTICAL FORMULATIONS [PDF]
A sensitive and accurate native spectrofluorimetric method was developed and validated for the quantification of Fluralaner in pharmaceutical formulations.
Yaser Reda +3 more
doaj +2 more sources
Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs [PDF]
Background Fluralaner (Bravecto™) is a novel systemic insecticide and acaricide that provides long persistent antiparasitic activity following a single administration at the minimum dose of 25 mg/kg body weight.
Janina Taenzler +6 more
doaj +3 more sources
Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions [PDF]
Background Year-round control of canine flea and tick infestations requires owner compliance with recommendations for regular treatments. Compliance failures can result in increased exposure of dogs to tick-borne pathogens and resurgence of flea ...
Ivo Petersen +8 more
doaj +2 more sources
Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the U.S., U.K., or France who treated their cats with transdermal fluralaner [PDF]
Background: Fluralaner (Bravecto®) is an isoxazoline class compound that is the only topically applied systemic ectoparasiticide approved for dosing at up to 12-week intervals for flea and tick control in cats.
Robert Philip Lavan +4 more
doaj +1 more source

